Article info

PDF
Original article
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

Authors

  • Elena Martínez-Terroba Program in Solid Tumors, CIMA, Pamplona, Spain Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Carmen Behrens Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jackeline Agorreta Program in Solid Tumors, CIMA, Pamplona, Spain Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Eduard Monsó Neumology Service, Parc Taulí Universitary Hospital, Sabadell, Spain CIBER de Enfermedades Respiratorias-CIBERES, Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Laura Millares Neumology Service, Parc Taulí Universitary Hospital, Sabadell, Spain CIBER de Enfermedades Respiratorias-CIBERES, Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Enriqueta Felip Vall d’Hebron University Hospital, Institute of Oncology, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Rafael Rosell Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain PubMed articlesGoogle scholar articles
  • José Luis Ramirez Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain PubMed articlesGoogle scholar articles
  • Ana Remirez Program in Solid Tumors, CIMA, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Wenceslao Torre Navarra Health Research Institute (IDISNA), Pamplona, Spain Department of Thoracic Surgery, Clínica Universidad de Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Ignacio Gil-Bazo Program in Solid Tumors, CIMA, Pamplona, Spain Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Miguel A Idoate Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Juan P de-Torres Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain Department of Neumology, Clínica Universidad de Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Ruben Pio Program in Solid Tumors, CIMA, Pamplona, Spain Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Ignacio I Wistuba Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • María J Pajares Program in Solid Tumors, CIMA, Pamplona, Spain Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Luis M Montuenga Program in Solid Tumors, CIMA, Pamplona, Spain Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain Navarra Health Research Institute (IDISNA), Pamplona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jackeline Agorreta and Professor Luis M Montuenga, Program in Solid Tumors, Center for Applied Medical Research (CIMA),Pamplona 31008, Spain; jagorreta{at}unav.es, lmontuenga{at}unav.es
View Full Text

Citation

Martínez-Terroba E, Behrens C, Agorreta J, et al
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

Publication history

  • Received June 12, 2018
  • Revised October 31, 2018
  • Accepted November 5, 2018
  • First published November 24, 2018.
Online issue publication 
March 14, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.